跳至主要内容
临床试验/NCT03689257
NCT03689257已完成不适用

Prospective and Multicenter Study About the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa16 个研究点 分布在 1 个国家目标入组 376 人开始时间: 2017年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
376
试验地点
16
主要终点
Incidence of IBD in Spain

研究概览

简要总结

This is a prospective, observational, multicenter, population-based incidence cohort study which will enroll cases of inflammatory bowel disease IBD (Crohn´s disease CD, ulcerative colitis UC, or indeterminate colitis) diagnosed in adults over 18 months in Spain.

In addition, each incident case that gave his/her informed consent, will be followed up for 12 months to determine changes in phenotype or disease location, the need for immunosuppressive and biologic treatments, and the need for hospital admissions and surgery during the first year after diagnosis.

Also, samples of of blood, urine and stool will be collected during the first year after diagnosis

详细描述

STUDY DESIGN This is a prospective, observational, multicenter, population-based incidence cohort study which will enroll cases of IBD (CD, UC, or indeterminate colitis) diagnosed in adults over 18 months in Spain.

In addition, each incident case that gave his/her informed consent, will be followed up for 12 months to determine changes in phenotype or disease location, the need for immunosuppressive and biologic treatments, and the need for hospital admissions and surgery during the first year after diagnosis.

Samples of blood, urine and stool will be collected during the study visits.

To achieve the aims this study will be Split in two studies.

  1. Epidemiology study to achieve aims 1 and 2.
  2. Characterization "omics" study to achieve aims 3, 4 and 5.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female ≥18 years of age diagnosed of inflammatory bowel disease
  • Diagnosis of IBD according to European Crohns and Colitis Organisation (ECCO) criteria.
  • The patient must belong to the health area of one of the participating center
  • Patients who have accepted to participate in the epidemiology study
  • < 1 month since the date of the diagnosis colonoscopy

排除标准

  • Patients who do not belong to the health area of the participating centers
  • Patients who do not accept to participate in the study
  • Patients who have initiated a treatment to IBD
  • Patients who received a immunomodulators to treat other disease
  • Patients with a immune-mediates systemic disease
  • Patients with a active infection or a malignancy in the baseline
  • Pregnant patients or breastfeeding

结局指标

主要结局

Incidence of IBD in Spain

时间窗: 1 year

Measure the incidence of IBD in Spain

次要结局

  • Characteristics of patients at diagnosis of inflammatory bowel disease and resources used in the first year after diagnosis(1 year)
  • Create a wide collection of samples(1 year)
  • Correlate the serum proteomic profile and the density(1 year)
  • Identify the molecular and cellular pathways involved with IBD development and pathogenesis.(1 year)

研究者

发起方
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
申办方类型
Other
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验